Creative Planning

Position in IOVA — Iovance Biotherapeutics, Inc.

CIK 1540235 OVERLAND PARK, KS

Position in IOVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$1,171,913

+$450,429 QoQ

Shares Held

281,710

+37.1% QoQ

Ownership

0.062%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#75

of 292 holders

Holding Since

Dec 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Creative Planning holds $452,608,635 across 219 Biotechnology names. IOVA ranks #75 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	127,672	$63,418,511
2	REGN	Regeneron Pharmaceuticals, Inc.	36,949	$23,039,178
3	EXEL	Exelixis, Inc.	270,292	$14,706,586
4	INCY	Incyte Corp	110,664	$12,544,870
5	CYTK	Cytokinetics Inc	141,939	$12,091,783
6	RVMD	Revolution Medicines, Inc.	64,120	$12,008,393
7	ARGX	Argenx SE	12,744	$11,823,500
8	BMRN	Biomarin Pharmaceutical Inc	153,161	$8,763,872

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,171,913	281,710	+37.1%	Shares	Sole	2026-08-13
2026-03-31	$721,484	205,551	+29.6%	Shares	Sole	2026-05-12
2025-12-31	$433,122	158,653	+59.9%	Shares	Sole	2026-02-17
2025-09-30	$215,324	99,228	+30.6%	Shares	Sole	2025-11-14
2025-06-30	$130,709	75,994	+16.6%	Shares	Sole	2025-08-08
2025-03-31	$217,076	65,188	+2.9%	Shares	Sole	2025-05-15
2024-12-31	$469,012	63,380	-13.8%	Shares	Defined	2025-02-14
2024-09-30	$690,061	73,489	+2.6%	Shares	Defined	2024-10-11
2024-06-30	$574,173	71,593	-7.1%	Shares	Defined	2024-08-15
2024-03-31	$1,142,072	77,063	+110.0%	Shares	Sole	2024-05-13
2023-12-31	$298,354	36,698	+140.4%	Shares	Defined	2024-02-14
2023-09-30	$69,455	15,265	+132.9%	Shares	Sole	2023-11-16
2021-03-31	$207,499	6,554	+48.0%	Shares	Sole	2021-04-30
2020-12-31	$205,505	4,429	—	Shares	Sole	2021-01-29
No filing history on record for this holder in this stock.